Circulating IGFBP-2 levels are correlated with metabolic dysfunction including obesity, diabetes, and insulin resistance as Igfbp-2 gene expression is lower in obese and diabetic patients28. Here, IGFBP2 is linked to obesity due to melanocortin 4 receptor deficiency.